Convatec Group (CTEC)

Sector:

Health Care

Index:

FTSE 100

240.40p
   
  • Change Today:
      2.40p
  • 52 Week High: 295.40p
  • 52 Week Low: 213.40p
  • Currency: UK Pounds
  • Shares Issued: 2,005.43m
  • Volume: 5,300,973
  • Market Cap: £4,821.06m
  • RiskGrade: 96

Convatec to expand R&D facilities in UK and US

By Abigail Townsend

Date: Wednesday 01 Oct 2025

LONDON (ShareCast) - (Sharecast News) - Convatec is to ramp up its research and development facilities in the UK and US, the medical products and technologies specialist said on Wednesday, as part of a $1bn decade-long investment plan.
The UK firm said it would open a new state-of-the-art centre in Manchester, slated for operation by 2027, and expand its facilities in Boston by the end of this year.

Around $600m will be invested in the US over the next decade, and £500m in the Manchester hub. The UK facilities will focus on all four of Convatec's core categories: advanced wound, ostomy, continence and infusion care.

The blue chip called the investment plan a "significant milestone" that underlined its commitment to both the US - which is responsible for about 57% of revenues - and UK.

As at 0900 BST, shares in Convatec were 1% higher at 232.91p.

A number of companies across the drugs and life sciences sectors are increasingly focusing investment plans on the US, to avoid the worst of Donald Trump's swingeing tariff regime.

In addition, both AstraZeneca and US giant Merck recently announced intentions to halt planned UK investments.

At the time, Merck blamed successive British governments for not investing heavily enough in the sector.

Convatec said on Wednesday said the UK remained an "attractive destination for life sciences, with a deep talent pool, strong research base and supportive environment for innovation.

"Convatec's plans, subject to government support, reflect our confidence in the UK's future as a global hub."

However, it noted: "It is critical that UK government policy, legislation, reimbursement decisions, and initiatives enable companies like Convatec to serve the best interests of patients, protect patient and provider choice and deliver value for taxpayers."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CTEC Market Data

Currency UK Pounds
Share Price 240.40p
Change Today 2.40p
% Change 1.01 %
52 Week High 295.40p
52 Week Low 213.40p
Volume 5,300,973
Shares Issued 2,005.43m
Market Cap £4,821.06m
RiskGrade 96

CTEC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.22% below the market average94.22% below the market average94.22% below the market average94.22% below the market average94.22% below the market average
15.15% below the sector average15.15% below the sector average15.15% below the sector average15.15% below the sector average15.15% below the sector average
Price Trend
26.97% above the market average26.97% above the market average26.97% above the market average26.97% above the market average26.97% above the market average
65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average
Income
69.27% below the market average69.27% below the market average69.27% below the market average69.27% below the market average69.27% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Growth
52.30% above the market average52.30% above the market average52.30% above the market average52.30% above the market average52.30% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average

What The Brokers Say

Strong Buy 7
Buy 7
Neutral 3
Sell 0
Strong Sell 0
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CTEC Dividends

  Latest Previous
  Interim Final
Ex-Div 21-Aug-25 17-Apr-25
Paid 01-Oct-25 29-May-25
Amount 1.88¢ 4.59¢

Trades for 13-Oct-2025

Time Volume / Share Price
16:36 4,231 @ 240.40p
16:36 8,462 @ 240.40p
16:36 5,694 @ 240.40p
16:36 6,381 @ 240.40p
16:36 4,850 @ 240.40p

CTEC Key Personnel

CEO Karim Bitar
Chair John McAdam
CFO Jonny Mason

Top of Page